Articles Published by the Ocular Immunology and Uveitis Foundation

C. Stephen Foster, M.D.

In Print (451-500)

Previous 50   Next 50

451. Ekong A, Foster CS, Roque M. 2001. Eye Involvement in Autoimmune Blistering Disease. Clin Dermatol 19:742-749. Abstract.

452. Michel SS, Ekong A, Baltatzis S, Foster CS. 2002. Multifocal Choroiditis and Panuveitis (MCP): Immunomodulatory Therapy. Ophthalmology 109:378-83. Abstract.

453. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtschig G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost C, Rogers RS. 2002. The First International Consensus on Mucous Membrane Pemphigoid: Definition, Diagnostic Criteria, Pathogenic Factors, Medical Treatment, and Prognostic Factors. Arch Dermatol 138:370-9. Abstract.

454. Foster CS. 2002. Understanding Mast Cell Heterogeneity. Rev Ophthalmol 9:86-7.

455. Abelson M, Foster CS, Gupta G. 2002. Diagnosing and Managing Anterior Uveitis. Review of Ophthalmolgy 110-114.

456. Foster CS. 2002. Book Review — Drug-Induced Ocular Side Effects, 5th Edition (Frauenfelder FT, Frauenfelder FW). Arch Ophthalmol 120:1002.

457. Foster CS, Papadaki TG. 2002. Diagnostic Evaluations to Guide Therapy for Anterior Uveitis. Contemp Opthalmol 1(10):1-8.

458. Samson CM, Nduaguba C, Baltatzis S, Foster CS. 2002. Limbal Stem Cell Transplantation in Chronic Inflammatory Eye Disease. Ophthalmology 109:862-8.

459. Akpek EK, Jabs DA, Tessler HH, Joondeph BC, Foster CS. 2002. Successful Treatment of Serpiginous Choroiditis with Alkylating Agents. Ophthalmology 109:1506-13. Abstract

460. Miserocchi E, Waheed NK, Dios E, Christen W, Merayo-Lloves J, Roque M, Foster CS. 2002. Visual Outcomes in HSV and VZV Uveitis: A Clinical Evaluation and Comparison. Ophthalmology 109:1532-7. Abstract

461. Razzaque MS, Foster CS, Ahmed AR. 2002. Role of Enhanced Expression of m-CSF in Conjunctiva Affected by Cicatricial Pemphigoid is Associated with Increased Accumulation of Macrophages. Invest Ophthalmol Vis Sci 43:2977-83.

462. Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS. 2002. Relapsing Polychondritis — A Clinical Review. Semin Arthritis Rheum 31:384-95.

463. Zacks DN, Samson CM, Loewenstein J, Foster CS.002. Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol 240:601-7. Abstract

464. Letko E, Bhol K, Colon J, Foster CS, Ahmed AR. 2002. Biology of interleukin-5 in ocular cicatricial pemphigoid. Graefes Arch Clin Exp Ophthalmol 240:565-9.

465. Chu DS, Foster CS. 2002. Sympathetic ophthalmia. Int Ophthalmol Clin 42:179-85. Abstract

466. Strauss EC, Foster CS. 2002. Atopic ocular disease. Ophthalmol Clin North Am 15:1-5. Abstract

467. Miserocchi E, Modorati G, Foster CS, Brancato R. 2002. Ocular and Extracutaneous Involvement in Pyoderma Gangrenosum. Ophthalmology 109:1941-3. Abstract.

468. Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS. 2002. The Effect of Treatment and its Related Side Effects in Patients with Severe Ocular Cicatricial Pemphigoid. NY Sight — NY State Ophthalmologic Society Summer:28-35.

469. Alio JL, Chipont E, BenEzra D, Fakhry MA, Foster CS, Baarsma GS, Beekhuis WH, Ohno S, Burtin T, Belfort R, Muccioli C, Uusitalo R, Juhas R, Garcia PH, Attia HE, Shalash R, Sainz de la Maza M. Comparative performance of intraocular lenses in eyes with cataract and uveitis. J Cataract Refract Surg 2002;28:2096-108.

470. Perez VL, Azar DT, Foster CS. Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease.  Semin Ophthalmol 2002;17:124-30.

471. Yu EN, Foster CS. 2002. Chronic Post-operative Endophthalmitis Due to Pseudomonas oryzihabitans. Am J Ophthalmol 134:613-4.

472. Foster CS. 2002. Ocular Whipple’s Disease. Ophthalmology 109:1952-3.

473. Papaliodis GN, Nguyen QD, Samson CM, Foster CS. Intraocular lens tolerance in surgery for cataracta complicata: Assessment of four implant materials. Semin Ophthalmol 2002;17:120-3.

474. Levinson RD, Park MS, Rikkers SM, Reed EF, Smith JR, Martin TM, Rosenbaum JT, Foster CS, Sherman MD, Holland GN. 2003. Strong Associations Between Specific HLA-DQ and HLA-DR Alleles and the Tubulointerstitial Nephritis and Uveitis Syndrome. Invest Ophthalmo Vis Sci 44:653-657. Abstract

475. Baltatzis S, Romero-Rangel T, Foster CS. 2003. Sectoral Keratitis and Uveitis: Differential Diagnosis. Graefes Arch Clin Exp Ophthalmol 241:2-7. Abstract

476. Batchelor TT, Kolak G, Ciordia R, Foster CS, Henson JW.. 2003. High-Dose Methotrexate for Intra-ocular Lymphoma. Clin Cancer Res 9:711-5. Abstract

477. Argüeso P, Tisdale A, Mandel U, Letko E, Foster CS, Gipson IK. 2003. The Cell-Layer — and Cell-Type — Specific Distribution of of GalNAc-Transferase in the Ocular Surface Epithelia is Altered During Keratinization. Invest Ophthalmol Vis Sci 44:86-92. Abstract

478. Foster CS, Rashid S. 2003. Management of Coincident Cataract and Uveitis. Curr Opin Ophthalmol 14:1-6. Abstract

479. Foster CS, Tufail F, Waheed NK, Chu D, Miserocchi E, Baltatzis S, Vredeveld CM. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol 2003;121:437-40. Abstract

480. Papaliodis GN, Chu DS, Foster CS. Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology 2003;110:786-9. Abstract

481. Iaccheri, Fiore T, Papadaki T, Androudi S, Foster CS. Adverse Reactions with Antitoxoplasma Therapy. Invest. Ophthalmol. Vis. Sci. 44: E-. Abstract 1415.

482. Razzaque MS, Foster CS, Ahmed AR. Role of collagen-binding heat shock protien 47 in ocular cicatricial pemphigoid conjunctival scarring. Invest Ophthalmol Vis Sci 2003;44:1616-21.. Abstract

483. Razzaque MS, Foster CS, Ahmed AR. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003;44:1998-2003. Abstract

484. Thakker MM, Perez VL, Moulin A, Cremers SL, Foster CS. Multifocal nodular episcleritis and scleritis in a patient with undiagnosed Hodgkin’s lymphoma. Ophthalmology 2003;110:1057-60. Abstract

485. Baltatzis S, Tufail F, Yu EN, Vredeveld CM, Foster CS. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology 2003;110:1061-5. Abstract

486. Stavrou P, Tufail F, Baltatzis S, Foster CS. Immunomodulatory treatment in patients with severe sympathetic ophthalmia. Middle East J Ophthalmol 2003;10:73-6. Abstract

487. Miserocchi E, Modorati G, Azzolini C, Foster CS, Brancato R. Herpes simplex virus type 2 acute retinal necrosis in an immunocompetent patient. Eur J Ophthalmol 2003;13:99-102. Abstract

488. Cunha RNP, Campos M, Dulley FL, Rojas B, Foster CS. Dry eye evaluation and immunohistochemical study of the conjunctiva and lacrimal gland of bone marrow transplantation patients. Arquivos Braileiros de Oftalmologia 2003. Abstract

489. Trocme SD, Leiferman KM, George T, Bonini S, Foster CS, Smit EE, Sra SK, Grabowski WR, Dohlman CH. Neutophil and eosinophil participation in atopic and vernal keratoconjunctivitis. Curr Eye Res 2003;26:319-25. Abstract

490. Razzaque MS, Kumari S, Foster CS, Ahmed AR. Expression profiles of collagens, HSP47, TGF-beta1,MMPs and TIMPs in epidermolysis bullosa acquisita. Cytokine 2003;21:207-13. Abstract

491. Razzaque MS, Ahmed BS, Foster CS, Ahmed AR. Effects of IL-4 on conjunctival fibroblast: possible role in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003;44:3417-23. Abstract

492. Ahmed AR, Dahl MV, Consensus Development Group. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol 2003;139:1051-9

493. Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster CS. Long-term progression, prognosis and treatment of patients with recurrent ocular manifestations of Reiter’s syndrome. Ophthalmology 2003;110:1764-9. Abstract

494. Yao L, Baltatzis S, Zafirakis P, Livir-Rallatos C, Voudouri A, Maromichelakis N, Zhao T, Foster CS. Human mast cell subtypes in conjunctiva of patients with atopic keratoconjunctivitis, ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Ocul Immunol Inflamm 2003;11:211-22. Abstract

495. Androudi S, Brazitikos P, Iaccheri B, Fiore T, Christen W, Meniconi M, Foster CS. Outsomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis. Graefes Arch Clin Exp Ophthalmo 2003;241:1000-5. Abstract

496. Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 2003;14:395-8. Abstract

497. Androudi S, Iaccheri B, Brazitikos P, Papadaki T, Foster CS. Bilateral chronic anterior uveitis & neuroophthalmologic manifestations in a patient with Churg-Strauss syndrome: an unusual ocular presentation. Ocul Immunol Inflamm 2004;12:59-63. Abstract

498. Razzaque MR, Foster CS, Ahmed AR. Role of macrophage migration inhibitory factor in conjunctival pathology in cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2004;45:1174-81. Abstract

499. Durrani K, Papaliodis G, Foster CS. Pulse IV Cyclophosphamide in Ocular Inflammatory Disease:efficacy and short-term safety. Ophthalmology 2004;111(5):960-5.

500. Zein G, Yu E, Tawansy K, Berta A, Foster CS. Neurofibromatosis type 1 associated with central nervous system lymphoma. Ophthalmic Genetics 2004;25:49-51. Abstract

Previous 50   Next 50

  • Educational Audio

    Click here to listen to
     Uveitis and Steroid-Sparing Therapy

    Presented by C. Stephen Foster, MD, FACS, FACR

    Audio-Digest Ophthalmology Volume 56, Issue 15

  • Twitter Feed